# Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever

> **NCT00237016** · PHASE2,PHASE3 · COMPLETED · sponsor: **Medical Corps, Israel Defense Force** · enrollment: 140 (—)

## Conditions studied

- Relapsing Fever, Tick-borne
- Jarisch Herxheimer Reaction

## Interventions

- **DRUG:** doxycycline treatment

## Key facts

- **NCT ID:** NCT00237016
- **Lead sponsor:** Medical Corps, Israel Defense Force
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-04
- **Primary completion:** —
- **Final completion:** 2003-04
- **Target enrollment:** 140 (—)
- **Last updated:** 2024-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00237016

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00237016, "Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00237016. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*